CMKLR1 and ovarian cancer: In silico analyses on the mRNA level (using gene chip data from 744 ovarian cancer patients accessed on the platform https://tnmplot.com) [38] on 15 September 2022 corroborated the positive correlation between chemerin (RARRES2) and CMKLR1 that had been observed on the protein level (Spearman’s rho = 0.26, p < 0.0001).